Lottin-Divoux Séverine, Barel Monique, Frade Raymond
INSERM U.672 (ex U.354), Immunochimie des Régulations Cellulaires et des Interactions Virales, Bâtiment G8, Génopole d'Evry, France.
FEBS Lett. 2005 Apr 25;579(11):2323-6. doi: 10.1016/j.febslet.2005.03.026.
RB18A (TRAP220/DRIP205) is a cofactor of transcription. We herein demonstrated that RB18A downregulated p53 and upregulated MDM2 promoters. These RB18A regulations, not modified by p53wt expression, were inhibited by mutant p53 (p53mut) expression, which directly interacts with RB18A D5 domain. In addition, RB18A via its D4 domain, also interacts directly and specifically with MDM2 protein inhibiting p53mut degradation. Altogether, these mechanisms contribute to maintain a high level of p53mut expression in tumor proliferating cells. Therefore, RB18A plays a central role to control p53wt and p53mut protein content and functions in cells through a loop of regulation, which involves MDM2.
RB18A(TRAP220/DRIP205)是一种转录辅因子。我们在此证明,RB18A可下调p53并上调MDM2启动子。这些不受p53野生型表达影响的RB18A调控作用,会受到与RB18A D5结构域直接相互作用的突变型p53(p53mut)表达的抑制。此外,RB18A通过其D4结构域,也与MDM2蛋白直接且特异性地相互作用,抑制p53mut的降解。总之,这些机制有助于在肿瘤增殖细胞中维持高水平的p53mut表达。因此,RB18A在通过涉及MDM2的调控环来控制细胞中p53野生型和p53mut蛋白含量及功能方面发挥着核心作用。